Literature DB >> 9489753

Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia.

J M Antunes Bras1, A L Epstein, S Bourgoin, M Hamon, F Cesselin, M Pohl.   

Abstract

Recombinant herpes simplex virus-1 encoding the rat preproenkephalin A (HSVLatEnk1) was generated for driving the expression of preproenkephalin A-derived peptides in dorsal root ganglia of rats in vivo. Three weeks after infection via the hind footpads, quantitative RT-PCR and in situ hybridization experiments showed a strong expression of preproenkephalin A mRNA in lumbar dorsal root ganglia. In addition, a 40-160% increase in radioimmunoassayable Met-enkephalin-like material concentrations was found in the dorsal spinal cord and dorsal root ganglia, respectively, at the lumbar level in HSVLatEnk1-infected rats as compared with animals infected with beta-galactosidase-encoding recombinant herpes simplex virus-1 or control rats. These data demonstrate the efficacy of the preproenkephalin A encoding vector and suggest that it should help in elucidating the role of Met-enkephalin-containing primary afferent fibers in pain transmission and/or control.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489753     DOI: 10.1046/j.1471-4159.1998.70031299.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

Review 1.  Genetic therapy for pain management.

Authors:  S P Wilson; D C Yeomans
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

3.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 4.  Viral vector-based gene transfer for treatment of chronic pain.

Authors:  Shuanglin Hao; Marina Mata; David J Fink
Journal:  Int Anesthesiol Clin       Date:  2007

5.  Effects of transgene-mediated endomorphin-2 in inflammatory pain.

Authors:  Shuanglin Hao; Darren Wolfe; Joseph C Glorioso; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2008-06-24       Impact factor: 3.931

6.  A new player in gene therapy for pain?

Authors:  M Pohl; D J Fink
Journal:  Gene Ther       Date:  2008-05-08       Impact factor: 5.250

7.  Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.

Authors:  Xiangmin Peng; Zhigang Zhou; Jian Hu; David J Fink; Marina Mata
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

Review 8.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

Review 9.  Applications of gene therapy to the treatment of chronic pain.

Authors:  Marina Mata; Shuanglin Hao; David J Fink
Journal:  Curr Gene Ther       Date:  2008-02       Impact factor: 4.391

10.  Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.

Authors:  Chris Towne; Marie Pertin; Ahmed T Beggah; Patrick Aebischer; Isabelle Decosterd
Journal:  Mol Pain       Date:  2009-09-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.